Mural Oncology PLC (MURA)
3.80
+0.04
(+1.06%)
USD |
NASDAQ |
May 02, 10:54
Mural Oncology Net Income (Quarterly): -59.54M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -59.54M |
September 30, 2023 | -51.28M |
Date | Value |
---|---|
December 31, 2022 | -48.58M |
September 30, 2022 | -50.64M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-59.54M
Minimum
Dec 2023
-48.58M
Maximum
Dec 2022
-52.51M
Average
-50.96M
Median
Net Income (Quarterly) Benchmarks
Amarin Corp PLC | -5.781M |
Jazz Pharmaceuticals PLC | 94.15M |
Prothena Corp PLC | -67.48M |
Iterum Therapeutics PLC | -12.36M |
GH Research PLC | -11.27M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 58.51M |
EPS Diluted (Quarterly) | -3.567 |
Enterprise Value | -207.22M |
Earnings Yield | -331.2% |